Resource Library
Asian countries take big tariff hits, but the semiconductor and pharma industries remain exempt… for now
The sweeping trade tariffs imposed by President Trump have sent global stock markets into turmoil. The APAC region has been hit particularly hard. But, for now, the semiconductor and pharma industries have been granted exemptions. How long will that last?
The forthcoming U.S. BIOSECURE Act is already making an impact on the China business strategy of global pharmaceutical companies. What are the implications for your China risk exposure?
Biopharmaceutical companies worldwide have expressed their intentions to continue investing in China. However, the forthcoming U.S. BIOSECURE Act means that many are proactively reassessing their China business strategies. Pamir has been working with pharma
How are China and Russia advancing their shared agendas?
Download our recent analyst paper to understand the key implications of recent China-Russia diplomatic developments.
Visit our Resources hub
